Methylphenidate Tied to Brain Changes in Boys With ADHD
Treatment with methylphenidate affects specific tracts in brain white matter in boys with attention-deficit/hyperactivity disorder.
Pediatrics
Prescription Drug Misuse Common in High Schoolers
Misuse of prescription drugs is common among high school students, and those misusing prescription drugs frequently obtain them from multiple sources.
Advocacy Needed for Unaccompanied Minors at Immigration Detention Centers
Medical professionals need to express their support for child advocacy programs to ensure that medical care is free from coercion and undue influences and is actually in the best interest of the child.
Nipocalimab Gets Fast-Tracked for Hemolytic Disease of the Fetus and Newborn
The Food and Drug Administration (FDA) has granted Fast Track designation to nipocalimab (M281) for the prevention of hemolytic disease of the fetus and newborn (HDFN).
Rotavirus Vaccine Led to Reduced Disease Prevalence, Season Duration
Implementation of rotavirus vaccination has reduced disease prevalence and season duration in the United States.
Symdeko Approved to Treat Younger Cystic Fibrosis Patients
The Food and Drug Administration (FDA) has approved Symdeko (tezacaftor/ivacaftor and ivacaftor; Vertex Pharmaceuticals) for the treatment of patients aged ≥6 years with cystic fibrosis (CF) who are homozygous for the F508del mutation or who have at least 1 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor. Previously,…
Is Melatonin Beneficial for Pediatric Patients With Sleep Disorders?
A recently published systematic review investigated the benefits and risks of melatonin supplementation for pediatric patients with sleep disturbances.
CHEST Guideline for Gastroesophageal Reflux and Chronic Cough in Children
Children with nonspecific chronic cough may not need to be routinely evaluated or treated with empirical therapy for gastroesophageal reflux without overt regurgitation.
First Anticoagulant Approved to Treat Symptomatic VTE in Pediatric Patients
The FDA has approved Fragmin, a low molecular weight heparin, for the treatment of symptomatic venous thromboembolism to reduce the recurrence of VTE in pediatric patients 1 month of age and older.
AAP Approves 2019 Recommendations for Preventive Pediatric Health Care
The American Academy of Pediatrics has approved the 2019 Recommendations for Preventive Pediatric Health Care, also known as the Periodicity Schedule.
